Effect of Vitamin D on neonatal respiratory distress

Early Phase 1

• Conditions: neonatal respiratory distress.; Respiratory distress syndrome of newborn; P22.0

• Registration Number: IRCT20190814044529N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All singleton pregnant women with a gestational age of less than 34 weeks, at risk of preterm delivery

Exclusion Criteria

Cardiovascular diseases (except for preeclampsia /eclampsia)
Asthma
History of certain illicit and prescription drugs(including narcotics, antiepileptic, non-steroid anti-inflammatory drugs, sedative-hypnotics, and tocolytics)
Multiple gestations

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eonatal respiratory distress reduction. Timepoint: 1-3 days after neonatal birth. Method of measurement: RDS will be diagnosed according to clinical criteria (tachypnea, subarachnoid retraction, grunting, groaning) and radiological criteria (volume reduction , Ground-glass, fading border of diaphragm and heart shadow).